Seizures and Adjunctive Rufinamide
Links shared publicly online about this topic
Epilepsy: Adjunctive Rufinamide Reduces Refractory Partial-Onset Seizures
medicalnewstoday.com — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial” View full resource at medicalnewstoday.com
Most Recently Shared on October 4, 2010 at 3:05 pm By:
Epilepsy: Adjunctive Rufinamide Reduces Refractory Partial-Onset Seizures http://mnt.to/3KJ7 #epilepsy
Adjunctive rufinamide reduces refractory partial-onset seizures
physorg.com — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS). Details of this study are now available online in Epilepsia, a journal published ...” View full resource at physorg.com
Most Recently Shared on October 1, 2010 at 9:51 am By:
PhysOrg Health News Health News
Adjunctive rufinamide reduces refractory partial-onset seizures http://tw.physorg.com/205131053
Adjunctive rufinamide reduces refractory partial-onset seizures
eurekalert.org — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures. Details of this study are now available online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.” View full resource at eurekalert.org
Most Recently Shared on October 1, 2010 at 7:35 am By:
Adjunctive rufinamide reduces refractory partial-onset seizures: ( Wiley-Blackwell ) Researchers from the Arkansas... http://bit.ly/c63jPJ
Adjunctive rufinamide reduces refractory partial-onset seizures
physorg.com — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS). Details of this study are now available online in Epilepsia, a journal published ...” View full resource at physorg.com
Most Recently Shared on October 1, 2010 at 1:48 pm By:
Adjunctive rufinamide reduces refractory partial-onset seizures: Researchers from the Arkansas Epilepsy Program fo... http://bit.ly/aaXVzP
Medical News: Rufinamide Cuts Partial Seizures - in Neurology, Seizures from MedPage Today
medpagetoday.com — “Adjunctive rufinamide (Banzel) significantly reduced total partial seizures in patients with inadequate response to up to three other antiepileptics, a randomized, placebo-controlled trial showed.” View full resource at medpagetoday.com
Most Recently Shared on October 3, 2010 at 2:37 am By:
Rufinamide Cuts Partial Seizures (CME/CE): (MedPage Today) -- Adjunctive rufinamide (Banzel) significantly reduced... http://bit.ly/d3gTY9
Adjunctive Rufinamide Reduces Refractory Partial-Onset Seizures: More than 50 percent reduction in partial seizure... http://bit.ly/bMqlMg
redorbit.com — “Adjunctive Rufinamide Reduces Refractory Partial-Onset Seizures: More than 50 percent reduction in partial seizure... http://bit.ly/bMqlMg” View full resource at redorbit.com
Most Recently Shared on October 2, 2010 at 3:15 pm By:
Adjunctive Rufinamide Reduces Refractory Partial-Onset Seizures: More than 50 percent reduction in partial seizure... http://bit.ly/bMqlMg
Banzel Oral Suspension Approved as Adjunct Therapy for Seizures - MPR
empr.com — “The FDA has approved Banzel (rufinamide; Eisai) oral suspension for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients 4 years old.” View full resource at empr.com
Most Recently Shared on March 4, 2011 at 3:28 pm By:
MPR News: Banzel Oral Suspension Approved as Adjunct Therapy for Seizures: The FDA has approved Banzel (rufinami... http://bit.ly/dGLofF
Rufinamide Cuts Partial Seizures (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Adjunctive rufinamide (Banzel) significantly reduced total partial seizures in patients with inadequate response to up to three other antiepileptics, a randomized, placebo-controlled trial showed.” View full resource at qualitypointtech.net
Most Recently Shared on October 1, 2010 at 9:12 pm By:
Rufinamide Cuts Partial Seizures (CME/CE): (MedPage Today) -- Adjunctive rufinamide (Banzel) significantly reduced... http://bit.ly/bNnZSi
Study demonstrates rufinamide therapy is effective in reducing partial seizure frequency
news-medical.net — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS).” View full resource at news-medical.net
Most Recently Shared on October 1, 2010 at 8:37 am By:
Epilepsy News: Study demonstrates rufinamide therapy is effective in reducing partial seizure frequency: Researche... http://bit.ly/aI5Ipa
FDA Approves BANZEL(R) (Rufinamide) Oral Suspension, 40 Mg/mL
medicalnewstoday.com — “Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved BANZEL® (rufinamide) Oral Suspension, 40 mg/mL, for the adjunctive treatment of seizures associated wit” View full resource at medicalnewstoday.com
Most Recently Shared on March 7, 2011 at 9:05 am By:
MNT Pediatrics News Pediatrics and Health News
FDA Approves BANZEL(R) (Rufinamide) Oral Suspension, 40 Mg/mL http://mnt.to/3RTV #pediatrics
FDA Accepts BANZEL(R) (Rufinamide) Oral Suspension NDA For Review
medicalnewstoday.com — “Eisai Inc. (Headquarters: Woodcliff Lake, NJ; President and CEO: Lonnel Coats), a U.S. subsidiary of Eisai Co., Ltd. (Headquarters: Tokyo; President and CEO: Haruo Naito) announced that the U.S.” View full resource at medicalnewstoday.com
Most Recently Shared on July 21, 2010 at 12:14 pm By:
FDA Accepts BANZEL(R) (Rufinamide) Oral Suspension NDA For Review http://mnt.to/3GmX #epilepsy
BANZEL ORAL SUSPENSION (Rufinamide) drug information from MPR
empr.com — “BANZEL ORAL SUSPENSION (Rufinamide) drug information for Seizure disorders from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on June 21, 2011 at 4:14 am By:
MPR News: BANZEL ORAL SUSPENSION: Monograph added. http://bit.ly/kTUIkv
Medical News: AAN: Broader Epilepsy Use Touted for Rufinamide - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “TORONTO -- Rufinamide (Banzel) was an effective treatment for refractory partial onset seizures in a phase III study, which could bring the drug to a much larger market, it was reported here.” View full resource at medpagetoday.com
Most Recently Shared on April 15, 2010 at 6:37 pm By:
AAN: Broader Epilepsy Use Touted for Rufinamide (CME/CE) TORONTO (MedPage Today) -- Rufinamide (Banzel) was an effectiv.. http://dld.bz/aurW
Lundbeck reports positive phase III study results for clobazam in the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome - Drugs.com MedNews
drugs.com — “Data from the pivotal clobazam study were presented at the American Epilepsy Society meeting in San Antonio, TX Two highest dosages of clobazam as add-on therap” View full resource at drugs.com
Most Recently Shared on December 8, 2010 at 3:07 pm By:
Drugs and Devices OW OW Health
Lundbeck reports positive phase III study results for clobazam in the adjunctive treatment of seizures ass... http://bit.ly/e8R9Xl #drug
Adjunctive brivaracetam for refractory partial-onset seizures: A randomized, controlled trial -- French et al. 75 (6): 519 -- Neurology
neurology.org — “Adjunctive brivaracetam for refractory partial-onset seizures: A randomized, controlled trial -- French et al. 75 (6): 519 -- Neurology” View full resource at neurology.org
Most Recently Shared on August 10, 2010 at 11:07 am By:
Adjunctive brivaracetam for refractory partial-onset seizures: A randomized, controlled trial: Conclusions: This i... http://bit.ly/dhhoI9
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Epilepsy News
The latest epilepsy news published daily. Articles from research centers, universities and prestigious journals.
-
PhysOrg Health News
PhysOrg.com Health and Medicine News Stories
-
Epilepsy OW
Organizing epilepsy resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
